Application of linc00540 in the diagnosis and treatment of rectal adenocarcinoma
A rectal adenocarcinoma, application technology, applied in the application field of LINC00540 in the diagnosis and treatment of rectal adenocarcinoma, can solve the problem of no significant improvement in the prognosis of colorectal cancer patients
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0067] Example 1 Screening for gene markers associated with rectal adenocarcinoma
[0068] 1. Sample collection
[0069] Samples of normal epithelial tissue adjacent to rectal adenocarcinoma and tissue samples of rectal adenocarcinoma were collected from 3 cases. All cases had not received chemotherapy and radiotherapy before surgery, and there were no other neoplastic diseases, autoimmune diseases and severe chronic diseases. Normal epithelial tissue adjacent to cancer Tissues were taken from 5cm from the upper edge of the tumor, and all patients gave informed consent, which was approved by the organizational ethics committee.
[0070] 2. Preparation of RNA samples
[0071] Tissue RNA was extracted using QIAGEN tissue RNA extraction kit, and the specific operation was carried out according to the instructions.
[0072] 3. Total RNA quantification and purity analysis
[0073] The above extracted RNA was subjected to agarose gel electrophoresis, the concentration and purity ...
Embodiment 2
[0094] Example 2 QPCR sequencing to verify the differential expression of LINC00540 gene
[0095] 1. Large-scale QPCR verification of the differential expression of the LINC00540 gene. According to the sample collection method in Example 1, 45 cases of normal tissues adjacent to rectal adenocarcinoma and 45 cases of rectal adenocarcinoma tissues were selected.
[0096] 2. RNA extraction
[0097] RNA samples were extracted using the QIAGEN Tissue RNA Extraction Kit. For details, please refer to the instruction manual.
[0098] 3. QPCR
[0099] 1) Reverse transcription reaction
[0100] Use FastQμant cDNA First Strand Synthesis Kit (Product No.: KR106) for reverse transcription of mRNA, first remove the genomic DNA reaction, add 5×gDNA Bμffer 2.0μl, total RNA 1μg, add RNase Free ddH 2 O Make the total volume to 10μl, heat in a water bath at 42°C for 3min, then add 2.0μl of 10×Fast RT Bμffer, 1.0μl of RT Enzyme Mix, 2.0μl of FQ-RT Primer Mix, RNase Free ddH 2 O 5.0 μl, after...
Embodiment 3
[0114] Example 3 Silencing of the LINC00540 gene
[0115] 1. Cell culture
[0116] Human rectal adenocarcinoma cell line HRC-99 was incubated in RPMI1640 medium containing 10% calf serum and 1% P / S at 37°C, 5% CO 2 , Cultivated in an incubator with a relative humidity of 90%. Change the medium once every 2-3 days, use 0.25% trypsin containing EDTA to routinely digest and passage, and take the cells in the logarithmic growth phase for the experiment.
[0117] 2. Design of siRNA
[0118] siRNA was designed according to the sequence of LINC00540 gene, the sequence of negative control siRNA-NC is shown in SEQ ID NO.5-6; the sequence of siRNA1-4 in the experimental group is shown in SEQ ID NO.7-14.
[0119] 3. Transfection
[0120] Divide the cells into 1×10 4 Inoculate / well into 24-well cell culture plates at 37°C, 5% CO 2 Cells were cultured in an incubator for 24 hours, and transfected in RPMI1640 medium containing no double antibody and containing 10% FBS according to the...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com